Please login to the form below

Not currently logged in
Email:
Password:

Accretio appoints Neil Levinson as strategy director

He joins the healthcare consultancy from Kaiser Associates

AccretioAccretio, part of the OPEN health group of companies, has appointed Neil Levinson as its strategy director.

Levinson will join the Accretio leadership team alongside managing director Richard Baderin and operations director Charlotte Richards.

Speaking of his new appointment, Levinson said: “Accretio has pioneered novel ways to support life science companies achieve improved results for their brand.

“I look forward to expanding this offering and maximising the breadth of experience from the broader OPEN Health group to provide outcomes-focused consulting and implementation services for global and UK clients.”

Most recently, Levinson was vice president at Kaiser Associates, a global strategy-consulting firm, where he led the European healthcare practice.

Prior to Kaiser, Levinson spent ten years at IMS Health, where he was senior principal, leading the UK and Ireland consulting services business.

Commenting on his appointment, Baderin, said: “Neil’s appointment cements Accretio’s evolution to a fully-fledged strategic solutions and implementation services company led by a team with pharmaceutical, consultancy and agency heritage.

“It’s great to have someone of Neil’s calibre as part of the leadership team as we embark on the next phase of Accretio’s journey.”

24th April 2018

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hanson Zandi

Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics